Maria Lucila Texeira de Andrade França
Research Subjects
Research Interests
Maria Lucila Texeira de Andrade França has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Anna Ludmylla Oliveira Mendes
Instituto Esperança de Ensino Superior
1 shared publication - Gabriel Padilla
Universidade de São Paulo
1 shared publication - Kamila Brielle Pantoja Vasconcelos
Instituto de saúde coletiva, Universidade Federal do Oeste do Pará—UFOPA, Santarém 68040-255, PA, Brazil
1 shared publication - Karine Rodrigues Do Nascimento Chaves
Graduanda em Biomedicina Instituto Esperança de Ensino Superior (IESPES) Travessa Luís Barbosa 1690 68040420 Carazanal Santarém -PA CEP
1 shared publication - Letícia Veras Costa Lotufo
Universidade de São Paulo
1 shared publication - Silvia Katrine Rabelo da Silva
Universidade Federal do Oeste do Para
1 shared publication
Latest Publications
- Open Access
- 12 June 2025
- Published by Portal de Periódicos UFU - Universidade Federal de Uberlandia in Hygeia - Revista Brasileira de Geografia Médica e da Saúde
- Vol. 21, e2138
BIOPROSPECÇÃO DE ACTINOBACTÉRIA ISOLADA DE ROCHAS CARBONÁTICAS NA AMAZÔNIA
Bioprospecting seeks to improve products and processes from natural resources. Despite the biotechnological potential of Actinobacteria, the Amazon remains underexplored in this context. The present study investigated the potential of a strain of Actinobacterium isolated from carbonate rocks in Amazonia region. For this purpose, a biochemical characterization was carried out, obtaining antitumor secondary metabolites and cytotoxic testing of Actinobacterians. The results showed that the bacterial strain PML5, exhibits promising for biotechnological and pharmacological applications. The morphology of the culture is consistent with the typical morphological profile of bacteria of genus Streptomyces. The biochemical characterization revealed the production of lipase, esterase and L-asparaginase enzymes, suggesting a diversified and adaptive metabolic potential of the strain. The antagonism test highlighted its remarkable antimicrobial activity against gram-positive and gram-negative pathogens. Most notably, the crude extract of the strain demonstrated 96% inhibition of cell growth in lineage of human colorectal cancer cells, suggesting the presence of bioactive compounds with anticancer potential. Therefore, this study contributes to the microbial biodiversity in the Amazon region, and also opens new perspectives, for the bioprospecting of Actinobacteria as sources of bioactive compounds and therapeutic agents.
- 12 June 2025
- Published by Portal de Periódicos UFU - Universidade Federal de Uberlandia in Hygeia - Revista Brasileira de Geografia Médica e da Saúde
- Vol. 21, e2138
Open AccessBIOPROSPECÇÃO DE ACTINOBACTÉRIA ISOLADA DE ROCHAS CARBONÁTICAS NA AMAZÔNIA
Bioprospecting seeks to improve products and processes from natural resources. Despite the biotechnological potential of Actinobacteria, the Amazon remains underexplored in this context. The present study investigated the potential of a strain of Actinobacterium isolated from carbonate rocks in Amazonia region. For this purpose, a biochemical characterization was carried out, obtaining antitumor secondary metabolites and cytotoxic testing of Actinobacterians. The results showed that the bacterial strain PML5, exhibits promising for biotechnological and pharmacological applications. The morphology of the culture is consistent with the typical morphological profile of bacteria of genus Streptomyces. The biochemical characterization revealed the production of lipase, esterase and L-asparaginase enzymes, suggesting a diversified and adaptive metabolic potential of the strain. The antagonism test highlighted its remarkable antimicrobial activity against gram-positive and gram-negative pathogens. Most notably, the crude extract of the strain demonstrated 96% inhibition of cell growth in lineage of human colorectal cancer cells, suggesting the presence of bioactive compounds with anticancer potential. Therefore, this study contributes to the microbial biodiversity in the Amazon region, and also opens new perspectives, for the bioprospecting of Actinobacteria as sources of bioactive compounds and therapeutic agents.